Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Ql2108's trials
A Phase Ⅲ Comparative Study of QL2108 to Dupixent®
QL2108 injection
Ongoing
Not yet recruiting
Phase 3
Open NCT06884891 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
